NRAS and KRAS mutations have distinct phenotypic effects on resulting tumors in CRC genetically engineered mouse models [53], and mutations at different codons even within NRAS cause different phenotypes [54]. The gene discussed is NRAS; the disease is colorectal carcinoma.